Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tolemy Bio
Cambridge, England, United Kingdomtolemy.bio ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Not applicable directly; company focuses on developing optimized media that enhance manufacturing efficiency and therapeutic outcomes rather than running clinical trials themselves.
- Therapeutic areas
- OncologyRegenerative MedicineOther
- Modalities
- Cell culture media tailored for immune cell therapies (CAR-T, TILs, CAR-NKs)Stem cell therapies (HSCs, MSCs, iPSCs)Gene therapy production systems using HEK293 cells producing AAV & LVV vectors
- Industry
- Non-Drug Biotech
02
Partnerships
Working with customers in advanced therapies sector; no named pharma partnerships disclosed yet
Beyond the preview
Go deeper on Tolemy Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tolemy Bio.